A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and claims of rapid UK delivery. Vendors market the substance there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.
Several professionals stated the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.
Platform Reaction and Material Removal
Based on the social media company, the platform has removed problematic material and prohibited associated hashtags and search suggestions. The company said it was dedicated to maintaining the service safe and allocating resources in enhancing compliance measures.
Digital Trading Operations
Investigations also found communities with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, filled with images of slimming results, glowing reviews and detailed guides for preparing or injecting at home.
Within minutes of joining one group, a vendor posted contact information, where most purchases take place. The seller sent an instruction manual and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.
Item Details and Pricing
Within these communities, messages show dark colored packages with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how long a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for Telegram stated it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service connected the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.
Her staff has previously encountered patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to potentially serious medical dangers”.
